Paper Review Records
All Paper Review Records
19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
64
days
The immunological paradox: immune checkpoint inhibitors in liver transplantation
Authors
Takashi Ito; Shinya Okumura; Katsunori Sakamoto; Etsuro HatanoShow moreShow less
Affiliations
1. Department of Surgery, Graduate School of Medicine, Kyoto University, Sakyo-Ku, JapanShow moreShow less
121
days
Combination of baseline and first-week neutrophil-to-lymphocyte ratio predicts overall survival in advanced renal cell carcinoma treated with first-line combination immunotherapy
Authors
Takeshi Sasaki; Shinichiro Higashi; Kouhei Nishikawa; Koji Iinuma; Keita Nakane; Tomoki Taniguchi; Yuta Sano; Aika Matsuyama; Kaori Ozawa; Kosuke Tochigi; Masataka Tamura; Yasuaki Kubota; Shusuke Akamatsu; Takuya Koie; Takahiro InoueShow moreShow less
Affiliations
1. Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu, Japan; 2. Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan; 3. Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 4. Department of Urology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan; 5. Department of Urology, Gifu Prefectural General Medical Center, Gifu, Japan; 6. Department of Urology, Yokkaichi Municipal Hospital, Yokkaichi, Japan; 7. Department of Urology, Okazaki City Hospital, Okazaki, Japan; 8. Department of Urology, Toyota Memorial Hospital, Toyota, Japan; 9. Tsu, JapanShow moreShow less
102
days
Intratumoral heterogeneity of intermediate CLDN18.2 expression in gastric cancer
Authors
Yusuke Kawanaka; Chiaki Inagaki; Masaki Okura; Seiichiro Mitani; Naoki Shiraishi; Kazuko Sakai; Kazuto Nishio; Yutaka Kimura; Yasutaka Chiba; Tomoko Wakasa; Hisato Kawakami; Hidetoshi HayashiShow moreShow less
Affiliations
1. Department of Medical Oncology, Kindai University Faculty of Medicine, Sakai, Japan; 2. Genome Medical Center, Kindai University Hospital, Sakai, Japan; 3. Department of Genome Biology, Kindai University Faculty of Medicine, Sakai, Japan; 4. Department of Surgery, Kindai University Nara Hospital, Ikoma, Japan; 5. Clinical Research Center, Kindai University Hospital, Sakai, Japan; 6. Department of Diagnostic Pathology, Kindai University Nara Hospital, Ikoma, Japan; 7. Department of Clinical Oncology, Tohoku University Graduate School of Medicine, Sendai, JapanShow moreShow less
136
days
Association between response to gemcitabine-based neoadjuvant therapy and efficacy of gemcitabine plus nab-paclitaxel for recurrent pancreatic ductal adenocarcinoma
Authors
Takumi Kinomoto; Kenji Ikezawa; Kunihito Gotoh; Yugo Kai; Ryoji Takada; Takanori Masumoto; Masaki Kawabata; Hiroki Kishimoto; Kana Ito; Makiko Urabe; Kaori Mukai; Tasuku Nakabori; Minoru Shigekawa; Hirofumi Akita; Hidenori Takahashi; Shogo Kobayashi; Kazuyoshi OhkawaShow moreShow less
Affiliations
1. Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan; 2. Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Amagasaki, Japan; 3. Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan; 4. Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan; 5. Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, JapanShow moreShow less
53
days
High therapeutic efficacy of triplet therapy in unresectable or metastatic colorectal cancer and its optimal application strategies
Authors
Hiroki Sakuyama; Hiroyuki Okuyama; Yoriyuki Tahara; Sena Tsukamoto; Ikuhiro Kita; Kotone Nomura; Akitsu Murakami; Yoshihiro Okita; Hironaga Satake; Takeshi Kato; Akihito TsujiShow moreShow less
Affiliations
1. Department of Medical Oncology, Kagawa University Hospital, Miki, Japan; 2. Department of Medical Oncology, Japanese Red Cross Society Himeji Hospital, Himeji, Japan; 3. Department of Medical Oncology, Kochi Medical School, Nankoku, Japan; 4. Department of Surgery, NHO Osaka National Hospital, Osaka, JapanShow moreShow less
110
days
Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer
Authors
Neal Shore; Nguyen; Barinder Kang; Amrita Sawhney; Clare Byrne; Jackson Tang; Magdaliz Gorritz; Chi-Chang Chen; Jeetvan PatelShow moreShow less
Affiliations
1. START Carolinas/Carolina Urologic Research Center, Myrtle Beach, USA; 2. Novartis Pharmaceuticals Corporation, East Hanover, USA; 3. Asclepius Analytics, New York, USA; 4. IQVIA, Wayne, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days